tranexamic acid has been researched along with amiloride in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Estensen, RD; Ludowese, C; Sinha, AA; Wilson, MJ | 1 |
| Dunbar, SD; Ornstein, DL; Zacharski, LR | 1 |
2 review(s) available for tranexamic acid and amiloride
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Cancer treatment with inhibitors of urokinase-type plasminogen activator and plasmin.
Topics: Amiloride; Animals; Antineoplastic Agents; Aprotinin; Diuretics; Fibrinolysin; Humans; Neoplasms; Serine Proteinase Inhibitors; Tranexamic Acid; Urokinase-Type Plasminogen Activator | 2000 |
3 other study(ies) available for tranexamic acid and amiloride
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.
Topics: Amiloride; Androgen Antagonists; Animals; Anti-Inflammatory Agents; Dactinomycin; Diuretics; Electrophoresis, Polyacrylamide Gel; Flutamide; Gene Expression Regulation; Hydrocortisone; Immunoblotting; Male; Orchiectomy; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Prostate; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Testosterone; Tranexamic Acid; Urokinase-Type Plasminogen Activator | 1996 |